Abstract
Gastroduodenal HCO3 - secretion is a key process that aids in preventing acid-peptic injury. Endogenous prostaglandins (PGs) play a particularly important role in the local control of this secretion. The secretion of HCO3 - in both the stomach and duodenum was increased in response to PGE2 as well as mucosal acidification, the latter occurring with concomitant enhancement of mucosal PG generation. These HCO3 - responses in the duodenum were markedly reduced by prior administration of the EP4 antagonist in rats, and profoundly decreased in the animals lacking EP3 receptors but not EP1 receptors. In contrast, gastric HCO3 - responses induced by PGE2 and mucosal acidification were prevented by the EP1 antagonist and disappeared in EP1, but not EP3-knockout mice. Consistent with these findings, duodenal HCO3 - secretion was stimulated by both EP3 and EP4 agonists but not EP1 or EP2 agonists, while gastric HCO3 - secretion was increased by the EP1 agonist but not EP2, EP3 or EP4 agonists. In addition, the HCO3 - stimulatory action of sulprostone (EP1/EP3 agonist) in the stomach was inhibited by the Ca2+ antagonist verapamil but not affected by IBMX, the inhibitor of phosphodiesterase, while that in the duodenum was inhibited by verapamil and enhanced by IBMX. Forskolin, the stimulator of adenlate cyclase, increased HCO3 - secretion in the duodenum but not the stomach. Thus, the HCO3 - stimulatory action of PGE2 in the duodenum is mediated by both EP3 and EP4 receptors being coupled intracellularly with both Ca2+ and cAMP, while that in the stomach is mediated by EP1 receptors, coupled with Ca2+.
Keywords: secretion, stomach, duodenum, prostaglandin, ep receptor subtypes, mucosal protection
Medicinal Chemistry
Title: Role of Prostaglandin E Receptor Subtypes in Gastroduodenal HCO3 - Secretion
Volume: 1 Issue: 4
Author(s): Koji Takeuchi, Eitaro Aihara, Masamune Hayashi and Yoko Sasaki
Affiliation:
Keywords: secretion, stomach, duodenum, prostaglandin, ep receptor subtypes, mucosal protection
Abstract: Gastroduodenal HCO3 - secretion is a key process that aids in preventing acid-peptic injury. Endogenous prostaglandins (PGs) play a particularly important role in the local control of this secretion. The secretion of HCO3 - in both the stomach and duodenum was increased in response to PGE2 as well as mucosal acidification, the latter occurring with concomitant enhancement of mucosal PG generation. These HCO3 - responses in the duodenum were markedly reduced by prior administration of the EP4 antagonist in rats, and profoundly decreased in the animals lacking EP3 receptors but not EP1 receptors. In contrast, gastric HCO3 - responses induced by PGE2 and mucosal acidification were prevented by the EP1 antagonist and disappeared in EP1, but not EP3-knockout mice. Consistent with these findings, duodenal HCO3 - secretion was stimulated by both EP3 and EP4 agonists but not EP1 or EP2 agonists, while gastric HCO3 - secretion was increased by the EP1 agonist but not EP2, EP3 or EP4 agonists. In addition, the HCO3 - stimulatory action of sulprostone (EP1/EP3 agonist) in the stomach was inhibited by the Ca2+ antagonist verapamil but not affected by IBMX, the inhibitor of phosphodiesterase, while that in the duodenum was inhibited by verapamil and enhanced by IBMX. Forskolin, the stimulator of adenlate cyclase, increased HCO3 - secretion in the duodenum but not the stomach. Thus, the HCO3 - stimulatory action of PGE2 in the duodenum is mediated by both EP3 and EP4 receptors being coupled intracellularly with both Ca2+ and cAMP, while that in the stomach is mediated by EP1 receptors, coupled with Ca2+.
Export Options
About this article
Cite this article as:
Takeuchi Koji, Aihara Eitaro, Hayashi Masamune and Sasaki Yoko, Role of Prostaglandin E Receptor Subtypes in Gastroduodenal HCO3 - Secretion, Medicinal Chemistry 2005; 1 (4) . https://dx.doi.org/10.2174/1573406054368657
DOI https://dx.doi.org/10.2174/1573406054368657 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diversity-Oriented Synthetic Approaches for Furoindoline: A Review
Current Organic Synthesis Nutrition and Nutritional Management of Crohns Disease in Children and Adolescents
Current Nutrition & Food Science Lifestyle Modification in Rheumatoid Arthritis: Dietary and Physical Activity Recommendations Based on Evidence
Current Rheumatology Reviews Aluminofluoride Complexes: Phosphate Analogues and a Hidden Hazard for Living Organisms
Current Inorganic Chemistry (Discontinued) Heme Oxygenase-Derived Carbon Monoxide Restores Vascular Function in Type 1 Diabetes
Drug Metabolism Letters Effects of <i>Piper sarmentosum</i> on Bone Health and Fracture Healing: A Scoping Review
Endocrine, Metabolic & Immune Disorders - Drug Targets The Anti-Inflammatory and Pharmacological Actions of Oleocanthal, a Phenolic Contained in Extra Virgin Olive Oil
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry SUBJECT INDEX TO VOLUME 1
Current Drug Targets Acute Passivation of Vulnerable Plaques with Wild-Type Apolipoprotein A-I in ApoE-Deficient Mice
Vascular Disease Prevention (Discontinued) What is the Optimal Treatment for Anemia in Inflammatory Bowel Disease?
Current Drug Delivery Optimizing Conventional Medical Therapies in Inflammatory Bowel Disease in 2014
Current Drug Targets Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?
Current Pharmaceutical Design Chemoprevention Gene Therapy (CGT) of Pancreatic Cancer Using Perillyl Alcohol and a Novel Chimeric Serotype Cancer Terminator Virus
Current Molecular Medicine The Association of Fractalkine Receptor (T280M) Polymorphism in the Pathogenesis of Acute Coronary Syndrome in the Egyptian Population
Current Pharmaceutical Biotechnology Drosophila melanogaster As a Model Host for the Study of Microbial Pathogenicity And the Discovery of Novel Antimicrobial Compounds
Current Pharmaceutical Design Plant Proteinases and Inhibitors: An Overview of Biological Function and Pharmacological Activity
Current Protein & Peptide Science Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults
Current Medicinal Chemistry Roles for Cavities in Protein Structure: New Insights
Current Proteomics Unveiling Novel Therapeutic Drug Targets and Prognostic Markers of Triple Negative Breast Cancer
Current Cancer Drug Targets Recent Patents in Antiviral siRNAs
Recent Patents on Anti-Infective Drug Discovery